A study to ascertain the prevalence of multiple sclerosis (MS) and motor neurone disease (MND) among the United Kingdom-born and various immigrant groups hospitalised in Greater London and in the West Midlands during the 13 years 1960-72 has been previously undertaken. 1 2 At this time a random sample of both the MS and MND records was coded so that the outcome of their disease could be ascertained.
Method
The random sample comprised 81 1 MS patients (15% of the initial population) and 838 The mean age at diagnosis in hospital for the MND patients who are now dead was 58 4 years for both men and women. This is about 10 years later than the mean age at which the MS patients were diagnosed in the hospitals in this study.
The mean age at death of these MND patients was 61-9 years for men and 61 4 years for women. Thus the average survival after hospitalised diagnosis was 3-5 years for men and 3 years for women. Forty MND patients were still alive (June 1985). This comprises 10-4% of the random sample of MND patients, 31 men and 9 women. The mean age at diagnosis in hospital for these patients was 51 5 years for men and 48 2 years for women. Thus, these patients were 6-9 years and 10 2 years, respectively, younger at the time of diagnosis in hospital than the MND patients who are now dead. The mean years for life after diagnosis of the living patients was 16 4 years for men and 18-1 years for women (June 1985) .
The case records of the 40 MND patients who are still alive were reviewed in order to study this group in greater detail. Twenty-one of the male patients' records are still available (68%) and, of these, 19 had an exclusive diagnosis and a further 3 had been diagnosed initially as having MND, but the diagnosis was subsequently changed. Six of the female patients' records were still available and all of those had an exclusive diagnosis of MND Seventy-six of the MND patients could not be traced (41 men and 35 women). This group of patients was compared with the traced MND patients (both alive and dead) with respect to age and sex (table 3) . There was no great difference between the two groups. Therefore the traced group is not a biased sample and there is no reason to believe that it would be easier to trace the living than the dead through the Central Register.
Discussion
The mean age at hospitalisation for the MS patients who are still alive was 39-1 years for men and 39-9 years for women. The reported mean age at first diagnosis of MS is about 30 years, and many of our MS patients may have been diagnosed earlier than the age at hospitalisation reported here. In the West Midlands, unlike in London, many of the hospitals did not have a diagnostic index which would have made it possible to verify whether an admission was a first admission, and therefore the time of first diagnosis, or a subsequent admission.
Of the MS patients who died, the mean age at death was 55-9 years for men and 57-9 years for women. A study conducted in the Netherlands on reported deaths from MS between 1950 and 1968 showed similar figures. They found that the mean age at death was 56-9 years for men and 55 2 years for women. 4 Frances O'Malley, Geoffrey Dean, and Marta Elian Of the MS patients who have died in this study, the average survival from the time of diagnosis was 7 4 years (men) and 10 5 years (women). Many studies have been carried out to assess survival, and there is wide variability. The early estimates of survival ranged from three to six years.5 Subsequent studies have estimated an average survival of between 13 and 20 years.6 8 In any series, the duration of the disease cannot be known accurately until all those in the study have died. Thus survival times derived from fatal cases are invariably too short. This is undoubtedly the case in our study.
The mean age at hospitalised diagnosis for the MND patients, both dead and alive (June 1985), was 57 2 years for men and 57-6 years for women (table 3) . These figures agree with those from similar studies carried out in other countries.9
The longevity of some of the MND patients is surprising. Of the patients who are now dead, 20% of the women and 27% of the men lived more than five years after hospitalised diagnosis, and, in fact, two of these patients lived up to 19 years after diagnosis in hospital. Also, 40 patients originally diagnosed as having MND are still alive (June 1985) . At present it is believed that the duration from clinical onset to death for MND patients is seldom more than three years.'0 On reviewing the death certificates of those patients for whom MS or MND was not recorded, it was noted that 69-0% of the male MS patients died of cardiovascular causes and 31 0% of the women had various forms of carcinoma recorded as the primary cause ofdeath. The main primary cause ofdeath in this group for both the male and female MND patients was acute respiratory infections (42-9% of the female deaths and 36-8% of the male deaths).
A further point of interest in these death certificates was that four patients (2 men and 2 women) who were originally diagnosed as having MND had MS recorded as the main cause of death. Also, one death certificate had both MND and MS recorded as primary causes of death, and as these two conditions are unlikely to co-exist in one patient, it is possible that the certifying doctor could not make up his mind as to which it was.
